Speakers’ Profile
Prof Jeff Dunn AO
President
Union for International Cancer Control
Prof. Jeff Dunn AO, an esteemed leader in cancer control and research, currently serves as the Chief of Mission and Head of Research at the Prostate Cancer Foundation of Australia. He holds a prestigious position as Professor of Social and Behavioural Science and Chair of Cancer Survivorship at the University of Southern Queensland.Prof. Jeff Dunn AO, significant contributions to cancer control, emphasising the social and behavioural aspects, span over 30 years and include over 200 publications. His leadership extends to being a Board Member and Chair of the Audit and Risk Committee for the West Moreton Hospital and Health Service.Recognised for his service, Prof. Jeff Dunn AO, was appointed an Officer in the Order of Australia (AO) in 2014. His presidency at the UICC since its virtual General Assembly on October 11, 2022 marks a pinnacle in his distinguished career dedicated to enhancing cancer survival and awareness.
Keynote Plenary 1
Topic: Building Global Partnerships for Comprehensive
Cancer Control: Strategies, Challenges, and Opportunities
Date: 21 June 2024
Time: 9:00 AM
Dr Khalid Bin Jabor Al-Thani, MD
Chairman
Qatar Cancer Society
His Excellency Sheikh Dr Khalid Bin Jabor Al Thani is the Founder and Chairman of Qatar Cancer Society and the University of Calgary in Qatar Board of Trustees Chair.
His Excellency served as Assistant Medical Director and Managing Director of Hamad Medical Corporation, Undersecretary for the Ministry of Public Health, Vice Chairman of the National Health Authority, and Chairman of the Permanent Licensing Committee for Healthcare Practitioners in Qatar.
Also, His Excellency served as Chairman of the Gulf Union Against Cancer, Qatar Foundation for the Elderly, and Board member of the Supreme Council for Family Affairs and the Shafallah Center for Children with Special Needs.
His Excellency is a Medical Doctor with a Bachelor of Medicine and Bachelor of Surgery from King Faisal University and graduated from Nova Southeastern University in Ft. Lauderdale, FL, USA with a Master of Healthcare Administration with emphasis on Planning and Budgeting.
Keynote Plenary 3
Topic: Driving Change: Qatar Cancer Society’s Impact on Cancer Awareness and Patient Support
Date: 21 June 2024
Time: 9:50 AM
Dr Rabindra Abeyasinghe
WHO Representative to Malaysia, Brunei Darussalam and Singapore
Dr. Rabi Abeyasinghe currently serves as the WHO Representative and Head of the WHO Country Office for Malaysia, Brunei Darussalam, and Singapore, based in Kuala Lumpur, Malaysia, since January 22, 2022. In this role, he spearheads strategic and policy dialogues with health ministries and partners. Previously, Dr. Rabi Abeyasinghe held positions including WHO Representative in the Philippines and Acting Director for Health Security and Emergencies at the WHO Regional Office for the Western Pacific, supporting the COVID-19 response.With nearly 30 years of experience in controlling vector-borne diseases, Dr. Rabi Abeyasinghe holds a Medical Specialist MD from the University of Colombo, Sri Lanka, along with advanced degrees from prestigious institutions.
Keynote Plenary 4
Topic: Contextualising Cancer Within the Sustainable Development Goals
Date: 21 June 2024
Time: 10:20 AM
Dr Ros Suzanna Ahmad Bustamam
Head of Oncology Specialty
Ministry of Health
Dr. Ros Suzanna A Bustamam is a clinical oncologist by training. She has been serving as the Head of the Department of Radiotherapy and Oncology at Hospital Kuala Lumpur since 2016. Concurrently she has been appointed by the Director General of Health Malaysia as the Head of Oncology Specialty, Ministry of Health of Malaysia (MOH). Her main responsibility is to lead the direction of radiotherapy and oncology services under MOH which include distribution and infrastructure planning, human resource, capacity building and training. Since 2016, she has been instrumental in the National Strategic Plan for Cancer Control Program. This program addresses cancer prevention and control from a holistic viewpoint that spans across primary prevention, screening, early detection, diagnosis, treatment, rehabilitation and palliative care. In addition, she possesses special interest in epigenetic studies for breast and gastric cancers and co-authored multiple journal publications that cover various aspects of cancer, including epidemiological and psychosocial. Beyond working hours, she enjoys reaching out to the public, especially in breast cancer awareness campaigns.
Keynote Plenary 5
Topic: Transforming Health Systems for Cancer Care: The Malaysian Perspective
Date: 21 June 2024
Time: 10:50 AM
Prof Darius Francescatti
Breast Onco Surgeon
Chicago, Illinois
Darius is a general surgeon in Chicago, Illinois, specializing in breast oncology for over 20 years. He earned his medical degree from Loyola University Chicago Stritch School of Medicine. His professional focus is on advancing technologies to improve surgical outcomes for breast cancer patients. He has been an early adopter of breast ultrasound, ductal lavage, ductoscopy, cryo and laser ablation of breast tumors, accelerated partial breast irradiation, intraoperative radiotherapy, and genomic molecular subtyping using Agendia’s Mammaprint.
Darius was employed by Mammaprint to assist with their US trials and recently developed a risk assessment tool based on breast thermography. Currently, his interests include intraoperative breast specimen analysis using advanced methodologies. His extensive background in education includes speaking and teaching at national and international conferences and educational venues sponsored by industry and medical societies.
His industry-related responsibilities have involved developing intellectual property, patent acquisition, creating educational materials for employees and customers, developing marketing materials, initiating white papers, and serving as an ombudsman for regulatory issues, bridging the clinical and commercial sectors. Darius’s comprehensive approach to breast cancer treatment incorporates all relevant technologies to better serve patients. He is also the author of “Breast Cancer – A New Era of Management.”
Keynote Plenary 6
Topic: Bench to Bedside to Boardroom
Date: 21 June 2024
Time: 2:30 PM
Prof Dr Elil Renganathan
Professor of Public Health & Policy
School of Medical and Life Sciences
Sunway University
Professor Elil is a senior international expert possessing significant leadership acumen and proficiency across various domains including public health, global health, evaluation, organizational learning, strategic planning, and governance. Throughout his extensive career spanning three decades, he has occupied numerous roles in public health, carrying diverse strategic and managerial duties. Notably, he spent over 24 years serving in leadership and global capacities within the World Health Organization (WHO). His most recent role involved serving as a Special Advisor to the high-level Panel for a Global Public Health Convention, demonstrating his ongoing commitment to shaping global health policies and initiatives. Throughout his career, Professor Elil has collaborated closely with governments, UN agencies, non-governmental organizations, and academic institutions, contributing significantly to advancing public health agendas on a global scale.
Topic: Panel Discussion: How Can We Do Better: Roles and Responsibilities of All Stakeholders in Fulfilling the Health Agenda
Date: 23 June 2024
Time: 2:30 PM
Dr Feisul Idzwan Mustapha
Director
Perak State Health Department
Ministry of Health
Dr. Feisul Mustapha is a senior medical consultant in public health best known for his leadership in the prevention and control of non-communicable diseases (NCDs) in Malaysia. His special areas of interest include diabetes, cardiovascular diseases, cancers and obesity. At the Ministry of Health Malaysia, he is currently the Director at the Perak State Health Department, responsible for the overall planning, coordination and implementation of all medical and public health programs and activities in the state of Perak.
He combines his high-level experiences in the government with active engagement of civil society and multilateral institutions. Dr Feisul is currently Chair of the Scientific Advisory Group for the Monash University South East Asia Community Observatory (SEACO). In addition, he is a Board Member for the International Advisory Board of the United Nations University – International Institute for Global Health (UNU-IIGH), and a Member of the Policy Advisory Group of the World Cancer Research Fund International (WCRF). He was previously a Member of the Strategic and Technical Advisory Group on the Prevention and Control of NCDs (STAG-NCD) for WHO Geneva.
In addition, Dr Feisul has special interest in leveraging on technology in catalysing behavioural modification to reduce the exposure to NCD risk factors.
Topic: Difficult Conversations – How to Advocate for People Living with Cancers
Theme: Advocacy and Policy
Session: Medical professionals
Date: 23 June 2024
Time: 11:20 AM
Dr. Hadi Mohamad Abu Rasheed, MD, PMP®, PCT® CGC®
Scientific Advisor
Head of the Cancer Awareness and Professional Development Department
Qatar Cancer Society
Dr Hadi is the Scientific Advisor and the Head of the Professional Development and Scientific Research Department and the Qatar Cancer Society (QCS). Dr Hadi is the representative member of the QCS in the National Cancer Governance Board in Qatar, the Gulf Federation for Cancer Control, the Union International for Cancer Control, the World Cancer Day Advisory Group, the World Ovarian Cancer Coalition, and the All.Can International. He is also an Adjunct Lecturer at the College of Health Sciences at The University of Doha for Science and Technology, preceptor at the Department of Public Health – College of Health Sciences – Qatar University, Psychology and Social Work Master’s Program at the Doha Institute for Graduate Studies, and Hamad Medical Corporation community medicine residency program.
Dr Hadi graduated from the University of Aleppo – Faculty of Medicine in Syria and completed his post-graduate training at the University of Iowa in the USA. Dr Hadi presented at more than 100 medical conferences and was involved as a Co-PI in research projects that have earnt grants of around half a million dollars in the USA and Qatar. Dr Hadi’s research interests are pediatric diseases, cancer burden, cancer education and awareness, continuing medical education, Knowledge Attitudes Perception studies related to cancer, quality of life of people living with cancer, health literacy, cancer survival studies, equity in cancer care, narrative medicine and cancer, palliative care, the role of civil societies in cancer control, social media and cancer awareness, and efficiency and efficacy in cancer control and public health.
Topic: Panel Discussion: How Can We Do Better: Roles and Responsibilities of All Stakeholders in Fulfilling the Health Agenda
Theme: Advocacy and Policy
Session: Research
Date: 23 June 2024
Time: 11:00 AM
Dr Noor Azura Noor Mohamad
Senior Lecturer/ Consultant Obstetrician and Gynaecologist (Gynaecologic Oncologist)
Dr Noor Azura Noor Mohamad graduated from Trinity College Dublin, Republic of Ireland in 2008. She gathered her clinical experience in Republic of Ireland until she obtained her membership from Royal College of Obstetricians and Gynaecologists in 2016. Subsequently, Dr Noor Azura Noor Mohamad returned to Malaysia to join Universiti Teknologi MARA in 2018.
Recently completed gynaecologic oncology subspecialty training under Kementerian Kesihatan Malaysia in December 2023, she was also awarded with Fellowship in Minimally Invasive Gynaecology Surgery by Yonsei University College of Medicine, South Korea in the same year.
Dr Noor Azura Noor Mohamad holds a position as senior lecturer in Obstetrics and Gynaecology in UiTM, and currently practices as consultant obstetrician and gynaecologist, and gynaecologic oncologist in Hospital Al-Sultan Abdullah.
Lunch Symposium by MSD
Date: 22 June 2024
Time: 12:30 PM
Dr Michael Wong Pak Kai
Colorectal and General Surgeon
Sunway Medical Centre
Dr Michael Wong Pak Kai is a highly skilled Colorectal and General Surgeon with extensive expertise in both surgical and endoscopic procedures. Fluent in English, Bahasa Malaysia, Mandarin, Cantonese, and Foochow, he ensures effective communication with a diverse range of patients. Graduating from the University of Sheffield in 2005, Dr Wong holds notable qualifications, including an MBChB and M Med Surgery, complemented by fellowships in Colorectal Surgery from Thailand and Malaysia.
His clinical focus encompasses conditions such as Colon & Rectal Cancer, Haemorrhoids, and Abdominal & Inguinal Hernias. His procedural expertise includes Minimally Invasive Colon & Rectal Surgery and advanced endoscopic techniques like Gastroscopy & Colonoscopy. Dr Wong’s dedication to advancing his field is evident through his postgraduate training and memberships in prestigious medical societies like the Malaysian Society of Colorectal Surgeons and the Academy of Medicine Malaysia.
Dr Michael Wong Pak Kai’s board certifications in General and Colorectal Surgery solidify his reputation as a leading authority in the field, making him a trusted choice for patients seeking specialized care in Colorectal, General, and Minimally Invasive Surgery, as well as Endoscopy.
Lunch Symposium by Sunway Medical Centre
Topic: The Importance of Early Colorectal Cancer Detection: The Role of Screening
Date: 22 June 2024
Time: 12:30 PM
Dr Hemmel Amrania
CEO
Digistain Ltd
Hemmel is a pioneering figure in medical technology, blending deep scientific expertise with entrepreneurial insight. As a Y Combinator alumnus and PhD graduate from Imperial College London in Physics with Biomedical Applications, he also holds an MSc from SupOptique at Université Paris XI. His academic contributions include a patented diagnostic method that revolutionized cancer diagnosis, earning him the President’s Award for Outstanding Research.
Mentored by Prof. Charles Coombes and Sir Nicholas Wright at Imperial College Hospital, Hemmel’s clinical trials have set new benchmarks in medical diagnostics. In 2021, he introduced Digistain, a technology from his research at Imperial College that cuts diagnostic wait times and costs, changing treatment decisions and improving cancer patient outcomes.
Globally recognized, Hemmel has received the Royal Society Innovation Prize and the Institute of Physics Innovation Award. He was also a finalist for the ‘Nature’ Innovation Prize, an honor shared by only four companies out of over 200 contenders, highlighting his work’s exceptional impact. Selected from 17,000 applicants for Y Combinator’s program, Hemmel exemplifies elite entrepreneurship. As he drives Digistain forward, his unique ability to integrate academic rigor with market-driven strategies sets new standards in healthcare technology and positions him as a vanguard in med-tech commercialization.
Lunch Symposium by Digistain
Topic: Performance of a Novel Reagent Free Tool For Supporting Adjuvant Therapy Decisions in Breast Cancer
Date: 23 June 2024
Time: 12:30 PM
Assoc Prof Dr Mengmeng Li
Associate Professor
Sun Yat-sen University Cancer Center
Dr. Mengmeng Li serves as an associate professor within the Department of Cancer Prevention at the Sun Yat-sen University Center (SYSUCC). Prior to her appointment at SYSUCC through the “100 Top Talents Program” in 2020, she held a position as a postdoctoral scientist at the International Agency for Research on Cancer (IARC), a specialized cancer agency of the World Health Organization (WHO).
As a cancer epidemiologist, Dr. Li is deeply committed to conducting research aimed at preventing cancer. Her ongoing projects primarily investigate the overdiagnosis of thyroid cancer, the influence of environmental factors such as air pollution on health, and the causes and screening methods for nasopharyngeal cancer.
Topic: Issues and Challenges in Implementation of Cancer Control
Theme: Prevention
Session: Allied Health Professionals
Date: 21 June 2024
Time: 11:50 AM
Prof Dr Victor Hoe Chee Wai Bin Abdullah
Professor of Occupational and Public Health
Department of Social and Preventive Medicine
Faculty of Medicine
University of Malaya
Dr Victor Hoe is a Professor of Occupational and Public Health. He heads the Academic Section in the Department of Social and Preventive Medicine, Faculty of Medicine in the University of Malaya and the Occupational Health, Safety and Environmental Unit in University Malaya Medical Centre. He started his career as an academic in 2004 when he joins the Department. His passion is in the use of technology to enhance and simplify work. He has been experimenting in various forms of online teaching and assessment since 2012. During the COVID-19 pandemic he was part of the team that transform the 8-weeks Community Posting programme for the undergraduate medical programme from a field posting to an online posting. The core of the programme of appreciating the diversity of medicine and public health was maintain through innovative approaches.
He holds a Doctor of Philosophy in Occupational Health and Safety from Monash University in Melbourne Australia. He also has the Master of Public Health, Master of Public Health (Occupational Health) and Master of Engineering (Safety, Health and Environment) from the University of Malaya, and the Master of Occupational Safety and Health from the University of Turin and the International Labour Organization (ILO) – International Training Centre in Turin, Italy. He is a Fellow of the Academy of Medicine Malaysia and Fellow of the Academy of Occupational and Environmental Medicine Malaysia. He was the recipient of the first of the two International Commission for Occupational Health (ICOH) and ILO Master Fellowship.
Topic: Occupational Cancer
Theme: Prevention
Session: Determinants of Health
Date: 21 June 2024
Time: 11:50 AM
Assoc Prof Dr Ho Weang Kee
Associate Professor, University of Nottingham
Wellcome Trust Research Fellow, Cancer Research Malaysia
Associate Professor Dr Ho Weang Kee, a Malaysian statistician and Associate Professor at the University of Nottingham Malaysia, focuses on statistical methods in genetic data analysis. Her pioneering work earned her the 2018 L’Oréal-UNESCO International Rising Talent Award for developing predictive models for breast cancer risk in Southeast Asian women. Ho’s academic journey began at Northumbria University, where she graduated with a BSc (Hons) in Mathematics in 2005 before pursuing a Ph.D. in Mathematics at Newcastle University.
Under the mentorship of biostatistician Robin Henderson, she explored statistical applications in scientific inquiries, culminating in her 2009 Ph.D. completion. Ho’s postdoctoral research spans diverse fields, including child speech and development studies at the National Institute for Health Research and medical and genetic statistics at the University of Cambridge.
Topic: The Role of Genomics in Global Cancer Prevention
Theme: Prevention
Session: Research
Date: 21 June 2024
Time: 11:15 AM
Dr Noraryana Binti Hassan
Deputy Director (NCD)
Disease Control Division
Ministry of Health Malaysia
Dr. Noraryana Binti Hassan disciplined and confident Public Health practitioner with Master of Public Health (MPH) Specialist in Health Promotion from Faculty of Medicine, University Malaysia Sarawak (2008) with extensive experience in the field concerned with the health of large populations in particular Non Communicable Disease. Worked with many different groups, families and communities as a whole, in advocating healthy lifestyle programs, for example helping individuals and groups to stop smoking and take more exercise. The vast exposures in examining public health issues and promote community awareness of them, will allow me to achieve remarkable gains and could make similar critical contributions to your esteemed organization and the health in this country as a whole.
Topic: Safer Smoking Products? Myth or Reality
Theme: Prevention
Session:Medical Professionals
Date: 21 June 2024
Time: 12:10 PM
Dr Balraj Sethi
Novartis Country Medical Affairs Head
Dr Balraj Sethi is a highly accomplished medical professional with extensive experience in the field of oncology and medical affairs. Currently serving as the Country Medical Affairs Head for Novartis in Malaysia, Dr. Sethi has played a pivotal role in shaping the organization’s medical strategies and initiatives.
With a Medical Degree from Ukraine and a Masters of Oncology from Germany, Dr Sethi possesses a strong academic foundation in the field. He has honed his expertise through his work in various renowned institutions, including his tenure at Novartis Corporation for the past 8 years, where he has held positions such as Oncology Medical Director and Medical Affairs Manager.
Prior to his association with Novartis, Dr Sethi served as a Medical Science Liaison for MSD Oncology, where he forged collaborations with key stakeholders in the healthcare industry. Furthermore, he also gained valuable clinical experience in both Australia and Malaysia, further solidifying his understanding of clinical practice.
Topic: Strengthening the Healthcare System for Prevention: A Public-Private Partnership Approach for Breast Cancer
Theme: Prevention
Session: Allied Health Professional
Date: 21 June 2024
Time: 12:10 PM
Dr Isabelle Soerjomataram
Medical Epidemiologist
Deputy Branch Head, Cancer Surveillance,
International Agency for Research on Cancer (IARC)
Dr. Isabelle Soerjomataram, an accomplished medical epidemiologist, focuses on the aetiology, prevention, and outcomes of cancer. After earning her medical degree in Indonesia, she advanced her expertise with a Master’s and PhD in the Netherlands.
Currently at IARC, her work centres on analysing the international variation in cancer burden and survival, using population-based datasets to understand how policy interventions can address the rising cancer burden. She leads and coordinates major projects, including global estimations of cancer’s attributable fractions to various risk factors like alcohol, tobacco, and obesity.
Notably, Dr. Isabelle co-chairs a comprehensive review assessing COVID-19’s impact on behaviours influencing future cancer burdens. Her leadership extends to pivotal cancer survival studies in both affluent and developing regions, evaluating health system effectiveness and the implications of disruptions like COVID-19 on cancer outcomes.
Topic: Global Cancer Data to Support Cancer Prevention and Control
Theme: Prevention
Session: Determinants of Health
Date: 21 June 2024
Time: 12:10 PM
Professor Dr Hamid Jan Bin Jan Mohamed
Professor of Nutrition & Deputy Dean,
School of Health Sciences,
Universiti Sains Malaysia
Professor Dr Hamid Jan Bin Jan Mohamed, a distinguished professor at the Nutrition Programme of Universiti Sains Malaysia (USM), has made significant contributions to nutrition science since joining USM in 2007, after completing his PhD at King’s College London. He pioneered the first Malaysian birth cohort study in 2009, the USM Pregnancy Cohort Study, which investigates the connections between maternal nutrition and the development of obesity and diabetes in offspring. His research also addresses the prevention of stunting in children and includes studies on breast and colon cancer.
Prof Hamid serves as the Deputy Dean of Research, Innovation, and Industry-Community Engagement at USM. He is deeply involved in national health policy, working with the Ministry of Health Malaysia as a key member and chairman of various technical working groups focused on nutrition. Additionally, he holds positions such as the vice-president of the Nutrition Society of Malaysia and is a Science Advisor for ILSI SEA Region, evidencing his broad influence in the field.
Topic: Malaysian Dietary Patterns and Colorectal Cancer Risk
Theme: Prevention
Session: Research
Date: 21 June 2024
Time: 12:10 PM
Dr Zdenko Herceg
PhD Head,
Branch of Epigenomics and Mechanisms,
International Agency for Research on Cancer (IARC-WHO)
Dr Zdenko Herceg has an international reputation as the leader in the application of epigenetic/epigenomic analyses to mechanistic and profiling studies of tumorigenesis and discovery of biomarkers of environmental exposures and cancer risk. He is currently Head of Branch of Epigenomics and Mechanisms at International Agency for Research on Cancer (Lyon, France). Prior to joining IARC, he was a post-doctoral scientist at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria. At IARC, Dr Herceg has developed and co-ordinated a number of multidisciplinary projects involving epigenomics and mechanistic studies involving international population-based studies. These include trend-setting initiatives for international interdisciplinary collaborations. These studies lead to conceptual breakthroughs and major advances in understanding molecular mechanisms of tumorigenesis and to discovery of powerful molecular biomarkers relevant to cancer causation and prevention. Dr Herceg authored more than 250 original peer-reviewed research publications (among which over 200 PubMed entries) in the field of epigenetics and cancer research.
Topic: Epigenetic Profiling of Biomarkers For Cancer Risk Assessment
Theme: Prevention
Session: Research
Date: 21 June 2024
Time: 12:30 PM
Prof Dr Leong Chee-Onn
CEO, AGTC Genomics Sdn Bhd
Adjunct Professor, Sunway University
Adjunct Professor, IMU
Prof. Leong Chee-Onn is a distinguished cancer biologist with a rich career that spans both academia and genomics innovation. Before establishing AGTC Genomics, he held the position of Deputy Director of Research and Professor at the International Medical University.
He was a Senior Research Fellow at Harvard Medical School and Massachusetts General Hospital. As of now, he is a Fellow of the Institute of Biomedical Sciences (FIBMS, UK), Fellow of the Royal Society of Biology (FRBS, UK), and Fellow of the Royal Society of Chemistry (FRCS, UK).
Prof. Leong has served as an adjunct professor at Sunway University, Universiti Tunku Abdul Rahman, Universiti Malaya, and the University of Nottingham. His work, particularly focused on oncology and cancer biology, showcases his commitment to advancing healthcare through education and research.
Topic: Liquid Biopsy and Circulating Tumour Cells (CTC): Prospective Approach
Theme: Screening and Diagnosis
Session: Medical professionals
Date: 22 June 2024
Time: 9:00 AM
Prof Dr Khatijah Abdullah @ Lim Geok Khim
Professor
Head of Department, Department of
Nursing,
Sunway University
Prof. Khatijah is a leading Nursing Professor and Department Head at Sunway University, Malaysia, with a robust background in clinical nursing andacademia since 1997. Recognised for her pivotal role in elevating the Nursing Department to achieve the Highest Publication Department accolade in 2018,she has significantly contributed to nursing education through initiating Malaysia’s first Masters in Nursing programme and mentoring over 25 PhD students.
Prof. Khatijah’s extensive research work encompasses over 50 peer-reviewed publications. She actively contributes to nursing standards and education as a Technical Committee Member of the Nursing Board Malaysia and holds key positions in qualitative research associations and editorial boards, demonstrating her profound impact on nursing education and practice both nationally and internationally.
Topic: Navigating Cancer Diagnosis Conversations: Best Practices and Pitfalls
Theme: Screening and Diagnosis
Session: Allied Health Professionals
Date: 22 June 2024
Time: 9:00 AM
Prof Dr Woo Yin Ling
Professor of Obstetrics and Gynaecology
Faculty of Medicine
University of Malaya (UM)
Dr. Woo is a consultant gynaecological oncologist renowned for her expertise in cervical cancer prevention and treatment of hereditary/familial gynaecological cancers. Her groundbreaking research on HPV immune-biology at the University of Cambridge earned her a PhD degree in 2008. Recognized for her clinical excellence, she was awarded the gold medal by the Royal College of Obstetrician and Gynaecologist for achieving the top rank in international examinations. Returning to Malaysia in 2010, she assumed a professorial role at University Malaya, where she translates her research into accessible knowledge, advising on policy development nationally and internationally. As a leading figure in HPV vaccination, Dr. Woo holds significant roles such as being the country representative for the Asia-Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN). She spearheads Program ROSE, a revolutionary cervical cancer screening initiative highlighted by the Economist Intelligence Unit and shortlisted for the 2018 UICC Collaborative award. Through ROSE Foundation, she ensures cervical cancer prevention is accessible to the underprivileged. Honored with the FIGO Awards in 2021 for her contributions to women’s health, Dr. Woo continues to collaborate with academic institutions, NGOs, and industries, striving to make cervical cancer a rare disease in our lifetime.
Topic: Eliminating Cervical Cancer in Malaysia: What Will it Take?
Theme: Screening and Diagnosis
Session: Determinants of Health
Date: 22 June 2024
Time: 9:00 AM
Dr Anand Sachithanandan
Co-founder & Immediate Past President,
Lung Cancer Network Malaysia
Professor Dr Anand Sachithanandan is a UK-trained, board-certified Cardiothoracic surgeon practising as an independent consultant at Sunway Medical Centre and Subang Jaya Medical Centre in Greater Kuala Lumpur. He has a special interest in the clinical management of lung cancer. Dr Sachithanandan is the founding President of Lung Cancer Network Malaysia (LCNM), a not-for-profit patient-centric NGO established in 2018, which seeks to improve local outcomes through greater awareness, education, and advocacy. He is a passionate advocate of multimodal therapy underpinned by multidisciplinary care to provide optimal holistic patient care.
Dr Sachithanandan has pioneered lung cancer screening here in Malaysia both with the use of LDCT imaging and, more recently, innovative AI technology. Screening aside, his research interests focus on biomarkers for better risk-stratification, patient selection, prognostication, and disease surveillance. Dr Sachithanandan is an Adjunct Professor of Surgery at University Malaya and sits on the Board of the London-based global Lung Cancer Policy Network and the Malaysian Council for Tobacco Control.
Topic: Integration of Artificial Intelligence (AI) in Lung Cancer Screening & Early Diagnosis
Theme: Screening and Diagnosis
Session: Research
Date: 22 June 2024
Time: 9:00 AM
Dr Tan Yuen Fen
General Manager
Cytovision Sdn Bhd
Dr Yuen-Fen Tan is an experienced Molecular & Clinical Biologist with extensive experience in project management and the establishment of commercial clinical laboratories. With a proven track record in designing and implementing laboratory setups, Dr Tan’s expertise is complemented by training in Good Manufacturing Practices (GMP) and certification in Good Clinical Practice (GCP). Prior to her current position at Cytovision Sdn Bhd. Dr Tan served as a postdoctoral fellow at University Tunku Abdul Rahman (UTAR), M Kandiah Faculty of Medicine and Health Sciences and held the positions as a Scientific Officer at MAKNA. She has been instrumental in spearheading External Quality Assurance (EQA) programs in diagnostic laboratories and contributed as a member of the R&D panel for the EQA at McPATH QAP Sdn Bhd under the Malaysian College of Pathologists. Cytovision Sdn Bhd is a pioneering Malaysian company at the forefront of On-Demand Digital Pathology, dedicated to transforming healthcare diagnostics through cutting-edge The dynamic collaboration fosters an environment where pioneering innovation meets academic rigor, resulting in a perfect synergy of expertise, knowledge and technology. It is established locally and has forged a powerful alliance between industry experts and distinguished academia, uniting a collective of seasoned pathologists, technical specialists, and researchers.
Topic: Emerging Role of Digital Morphology in Precision Diagnostics
Theme: Screening and Diagnosis
Session: Medical Professionals
Date: 22 June 2024
Time: 9:20 AM
Dr Flora Chong
Clinical Oncologist
Hospital Wanita dan Kanak-Kanak Sabah
Dr Flora Chong Li Tze is a Clinical Oncologist and Head of the Radiotherapy and Oncology Department at Hospital Wanita dan Kanak-Kanak Sabah (also known as Likas Hospital) in Kota Kinabalu, Sabah. She is also the Head of the Clinical Research Centre at her hospital as well as Head of Oncology Services in Sabah. She is enthusiastic in improving access to cancer care outside tertiary centre in Kota Kinabalu.
Topic: Panel Discussion: Partnership for Cancer Funding Innovation
Theme: Treatment
Session: Determinants of Health
Date: 22 June 2024
Time: 2:40 PM
Topic: Enhancing Skills-Based Training in Screening, Diagnosis and Treatment
Theme: Screening and Diagnosis
Session: Allied Health Professional
Date: 22 June 2024
Time: 9:20 AM
Dr Mohamed Abdullah Mohamed Al Lamki
Senior Consultant, Endocrinology
Oman International Hospital
Dr Mohamed Abdullah Mohamed Al Lamki (MBBCH, MSc Endocrinology, FRCP(UK)) is a Senior Consultant in Endocrinology. Dr Lamki earned his undergraduate degree from Ein Shams University in Cairo, Egypt, and completed his higher education at King Williams College in the Isle of Man, United Kingdom. Following his postgraduate studies in Glasgow, Scotland, he became the first Omani Endocrinologist and joined the Ministry of Health in Oman.
Dr Lamki has extensive experience in managing diabetes, obesity, and diabetes technology, as well as endocrine metabolic diseases, thyroid, parathyroid, and thyroid cancer. He is an expert in pituitary and adrenal disorders and is well-versed in neuro-endocrine oncology, bone and mineral disorders, and the rare disorder porphyria. His expertise and pioneering contributions make him a respected authority in the field of endocrinology.
Topic: The Genetics of Cancer and its Role in Screening and Diagnosis
Theme: Screening and Diagnosis
Session:Determinants of Health
Date: 22 June 2024
Time: 9:20 AM
Prof Dr Chong Pei Pei
Digital Health and Innovations Impact Lab Director
School of Biosciences
Faculty of Health & Medical Sciences
Taylor’s University
Professor Dr. Chong Pei Pei, Lab Director at Taylor’s University, leads innovative research projects in health and medical sciences. She has secured over 2 million in research grants and holds patents for her work. Embracing digital technologies, she collaborates across disciplines to tackle health challenges.
Since joining Taylor’s University, she has won multiple research grants and leads projects focusing on issues like pornography addiction among children and automated cancer cell detection. Additionally, she teaches undergraduate courses and leads a postgraduate module on Research Methods for Science, inspiring students to conduct impactful research
Topic: Cervical Cancer Screening, Integration with AI
Theme: Screening and Diagnosis
Session: Research
Date: 22 June 2024
Time: 9:20 AM
Dr Nur Adila binti Anuar
Consultant Physician and Haematologist
KPJ Ampang Puteri
Dr Nur Adila Anuar graduated with an MBBS and Masters in Internal Medicine, both from the University of Malaya. Prior to joining private practice, Dr Nur Adila served at University of Malaya Medical Centre (UMMC) and University of Malaya Specialist Centre (UMSC) as a Senior lecturer and Consultant Physician/Haematologist.
Dr Nur Adila played an active role in Malaysian medical research, publishing several high impact research papers, invited to speak at local and international events. She currently holds a Fellowship in Haematology at the Malaysian Society of Haematology where she received her Certificate of Specialist Training in Haematology. Her early root in medical research continue to drive her passion to stay up to date on the latest medical developments in her field and provide the best options for those under her care
Topic: An Introduction to Blood Cancers and Their Diagnosis
Theme: Screening and Diagnosis
Session: Medical Professional
Date: 22 June 2024
Time: 9:40 AM
Dr Arunah Chandran
Public Health Officer
(Early Detection, Prevention & Infections Branch)
International Agency for Research on Cancer (IARC)
Dr. Chandran is a Public Health Physician with 16 years of progressive experience in clinical medicine, health systems, and implementation research. Having previously led the national policy response for NCDs in Malaysia, she currently serves as a Public Health Officer at the International Agency for Research on Cancer (IARC/WHO). Her role at IARC/WHO focuses on developing, implementing, and evaluating equitable multi-cancer early detection packages to improve cancer outcomes in different economies. Initially trained as a physician, Dr. Chandran holds double Masters in Public Health and Medical Aesthetics/Anti-aging, as well as a Doctorate in Public Health (Epidemiology).
Topic: Cancer Early Detection: Applying The Lens of Context to Improve Outcomes
Theme: Screening and Diagnosis
Session: Determinants of Health
Date: 22 June 2024
Time: 9:40 AM
Prof Cheong Sok Ching
Chief Scientific Officer,
Cancer Research Malaysia
Dr Cheong is the Chief Scientific Officer at Cancer Research Malaysia and Adjunct Professor at the Faculty of Dentistry, University of Malaya. Her work aims to improve management and survival of cancer patients through the understanding of the underlying molecular changes, and through the development of novel treatment approaches, focusing on head and neck cancers.
Her work includes the development of immunotherapy and the use CRISPR-Cas9 essential screens to identify novel targets for head and neck cancer. In addition, she also focuses on early detection using innovative strategies including the development of novel mobile health tools. She has received grants from national and international funding bodies including the Newton-Ungku Omar Fund, Newton Fund Impact Scheme, Global Challenges Research Fund and the Ministry of Science, Technology and Innovation SMART Fund, amongst others. In recognition of her research contributions, she has received several national and international scientific awards, including the President’s Award by the International Association of Oral Maxillofacial Pathologist (IAOP), the 8th Underwriters Laboratories-ASEAN-US Science Prize for Women 2022 and The World Academy of Sciences (TWAS) Medal Lecture.
Topic: Mobile Technology for Screening and Follow Up of OPMD and Oral Cancer
Theme: Screening and Diagnosis
Session: Research
Date: 22 June 2024
Time: 9:40 AM
Dr Tran Le Son, PhD
Principal Investigator,
Oncology Division, Gene Solutions
Dr Le Son TRAN is a principal investigator at Gene Solutions and the Medical Genetics Institute in Vietnam, focusing on multi-cancer early detection and liquid biopsy assay development. With nearly 15 years in molecular biology, immunology, and cancer genomics, he has worked in top labs in Australia, France, Singapore, and Vietnam, advancing non-invasive cancer diagnostics via ctDNA analysis.
Dr Tran holds a Ph.D. in Immunology and Cancer Biology from the University of Queensland. He completed postdocs at the Hudson Institute of Medical Research in Melbourne and the Institute of Molecular and Cell Biology A*STAR in Singapore, specializing in molecular genomics and immunology.
At Gene Solutions, Dr Tran leads a team developing innovative liquid biopsy assays for early cancer detection, integrating genomics, bioinformatics, and machine learning. His team developed a multi-cancer detection platform using cell-free DNA methylation and ctDNA fragmentomics. He has published in high-impact journals like Nature Communications and Elife and received multiple awards, including from ASCO Breakthrough and ESMO Asia. Dr. Tran is an active member of the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO).
Topic: Analytical and Clinical Validation of a Circulating Tumor DNA-Based Assay for Multi-Cancer Early Detection
Theme: Screening and Diagnosis
Session: Medical Professionals
Date: 22 June 2024
Time: 10:00 AM
Dr Roziana Ariffin
Consultant Cytogeneticist & Molecular Pathologist,
President of the Chapter of Medical Genetic College of Pathology Malaysia,
President of Medical Genetics Society of Malaysia
Dr Roziana Ariffin is a Consultant Cytogeneticist & Molecular Pathologist. She graduated from medical school USM & then continue her post graduate Masters in Histopathology in UKM. She then went for her subspecialty and fellowship in cytogenetics and molecular pathology training in UK followed by multiple numerous short & long courses in Dublin, Cambridge, Australia & Japan.
She is a pioneer in genetics diagnostics in Malaysia. She first started the molecular genetics lab service in MOH in 2008 with HKL molecular genetics lab being the one and only lab in the public service offering molecular genetics and cancer genetic testing in Ministry of Health Malaysia then. She helped started the cytogenetics lab service in Prince Court Medical Center which now had all been integrated into one lab & Premier Integrated Labs (PIL) at Pantai Hospital Kuala Lumpur. In addition, she helped started the cytogenetics lab in UMMC as well.
Currently she is the residential pathologist @ Premier Integrated Labs and a visiting consultant in Sunway Medical Center. She is also the President of the Chapter of Medical Genetic College of Pathology Malaysia & President of Medical Genetics Society of Malaysia.
Topic: AI For Cancer Pathology : Unveiling Tomorrow’s Possibilities
Theme: Screening and Diagnosis
Session: Research
Date: 22 June 2024
Time: 10:00 AM
Prof Dr Chin Sze-Piaw
Consultant Physician & Cardiologist
ReGen Rehab Hospital, Petaling Jaya
Prof Chin earned his specialist credentials from the British Royal College of Physicians (MRCP) in 1998 and was honored with a fellowship from the National Heart Association of Malaysia in 2008 for his contributions to cardiovascular medicine. As an experienced internist and interventional cardiologist, his research has focused on stem cells and cellular molecular signaling. He has held the position of committee member and past chairman of the National Stem Cell Registry and has been involved in various expert committees concerning Clinical Practice Guidelines. Prof Chin’s scholarly work, including numerous publications and presentations on heart disease and stem cells, has received international recognition. Notably, he led groundbreaking research in using stem cells for treating severe heart failure and was among the pioneers in differentiating stem cells into nerve, kidney mesangial, and insulin-producing cells for diabetic patients. Currently, Prof Chin dedicates his efforts to exploring the potential of stem cells in health promotion, anti-aging, and disease prevention.
Topic: Has Immune Cells Therapy Come of Age?
Theme: Treatment
Session: Medical professionals
Date: 22 June 2024
Time: 2:00 PM
Ms Betti Sharina Mohd Haniff Lai
Dietitian
National Cancer Institute, Putrajaya
Ms Betti Sharina is a clinical dietitian for the past 14 years and has 10 years of experience in managing oncology patients in Institut Kanser Negara, Putrajaya particularly patients ongoing chemotherapy and radiotherapy. She actively involves in clinical audit, clinical research and innovation. She also has strong interest in nutritional management for head and neck cancer and has done many clinical audit and research in this area. She always committed to ensure patients receive evidenced-based and updated medical nutrition therapy.
Topic: Optimising Cancer Patient Outcomes: The Role of Medical Nutrition Therapy in Supporting Treatment
Theme: Treatment
Session: Allied Health Professionals
Date: 22 June 2024
Time: 2:00 PM
Prof Dr Kenneth Lee Kwing Chin
Professor of Health Economics
School of Medicine
Monash University Malaysia
Prof. Kenneth Lee, a distinguished figure in pharmacoeconomics and outcomes research, received his pharmacy training from the University of Washington and pursued higher qualifications at the Chinese University of Hong Kong and the University of Oxford.
During his 18-year tenure at CUHK School of Pharmacy, he became renowned for his contributions to comparative effectiveness research and healthcare policy. He’s Editor-in-chief of the Journal of Medical Economics and holds adjunct and honorary professorships.
A key figure in the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), he founded the ISPOR Asia Consortium and chaired the ISPOR Hong Kong Chapter. He’s served on numerous ISPOR committees, taught ISPOR courses, and was elected to the Board of Directors. He was the co-chairman of the Scientific Committee for ISPOR’s Asia Pacific Conference in Singapore 2016. He is also one of the co-editors of Value in Health Regional Issue.
Currently, he is a Professor at the School of Pharmacy, Faculty of Health & Medical Sciences, Taylor’s University.
Topic: Cost of Cancer
Theme: Treatment
Session: Determinants of Health
Date: 22 June 2024
Time: 2:00 PM
Prof Dr Nirmala Bhoo Pathy
Professor of Epidemiology and Public Health
Faculty of Medicine
University of Malaya
Prof. Nirmala Bhoo-Pathy is a distinguished epidemiologist and public health physician at Universiti Malaya, advocating for the welfare of cancer patients and their families, particularly in low- and middle-income countries. A leading voice in oncology, she contributed to the “Women, Power, and Cancer” Lancet Commission and actively supports its implementation in Asia, along with serving on commissions focused on cancer and health systems and the humanitarian aspects of cancer.
Motivated by the need to balance biomedical and humanitarian perspectives in cancer care, she established the “Well with Cancer in Malaysia” research group and led the influential ASEAN Costs in Oncology (ACTION) Study, which has informed cancer policy in LMICs.
Prof. Nirmala is committed to shaping global cancer policy to ensure equitable access to high-quality care for all individuals.
Topic: Trends of Breast Cancers over 15 years
Theme: Research
Session: Determinants of Health
Date: 23 June 2024
Time: 2:00 PM
Dr Malwinder Singh Sandhu
Clinical Oncologist
Pantai Hospital, Kuala Lumpur
Dr Malwinder Singh graduated from Melaka Manipal Medical College in 2006 with a Bachelor of Medicine and Bachelor of Surgery (M.B.B.S.) degree. He also obtained Master of Clinical Oncology (M.Co) in 2015 from University Malaya. He received his training in stereotactic radiotherapy (SBRT/SRS/SRT) at Tata Memorial Hospital in India and now specializes in Gamma Knife for brain tumours and SBRT for prostate and lung cancers. He has a special interest in breast, colon, lung, prostate and brain cancers. He has worked as an oncologist for the Ministry of Health at Hospital Sultan Ismail and Hospital Kuala Lumpur.
Topic: A Brief Overview on the Latest Cancer Treatment in the 21st Century
Theme: Treatment
Session: Medical Professionals
Date: 22 June 2024
Time: 2:20 PM
Assoc Prof Dr Caryn Chan
Lecturer
Community Health Research Center (ReaCH), Universiti Kebangsaan Malaysia (UKM)
Associate Professor Dr. Caryn Mei Hsien Chan is a psychologist renowned for her dedication to empowering and educating patients coping with chronic illnesses. Her research focus encompasses health promotion and the implementation of psychological strategies in the primary and secondary prevention of non-communicable diseases (NCDs). Assoc. Prof. Dr. Chan’s expertise is particularly prominent in the field of psychosocial oncology, where she delves into psychological issues surrounding cancer.
Within this domain, she specializes in exploring adaptation and adherence to cancer treatment among patients and survivors, as well as examining coping mechanisms among caregivers. Assoc. Prof. Dr. Chan serves as the principal lead for several large-scale prospective cohort studies, which meticulously monitor patients’ psychological well-being through comprehensive psychological assessments conducted shortly after diagnosis and treatment, and consistently at regular intervals in the subsequent months and years. Her work significantly contributes to advancing our understanding of the psychological aspects of cancer care and improving support systems for individuals affected by the disease
Topic: Incorporating Psychological Approaches for Unmet Supportive Care Needs
Theme: Treatment
Session: Allied Health Professionals
Date: 22 June 2024
Time: 2:20 PM
Mr Billy Urudra
Executive Director
Malaysian Organisation of Pharmaceutical Industries (MOPI)
Mr Billy Urudra is the Executive Director of the Malaysian Organization of Pharmaceutical Industries (MOPI). Previously, he was the President of MOPI from July 2018 to June 2023. In his role as Executive Director, he engages with various Government Ministries in Malaysia to ensure policies support the development and growth of the local pharmaceutical industry.
He has successfully re-branded MOPI and established it as a key stakeholder in developing Government policies related to the Malaysian pharmaceutical industry. Mr Urudra is also a consultant, providing advisory, business development, and human resource development services for the pharmaceutical industry. He has over 40 years of working experience in leadership, line, and functional roles across various businesses within ICI, CCM, and Duopharma Group. In 2012, he became the Chief Commercial Officer for Duopharma Biotech Berhad, a leading pharmaceutical company in Malaysia, where he led all commercial activities locally and internationally. He has 23 years of experience in the pharmaceutical industry.
Mr. Urudra is a member of the Advisory Panel of the Chemical Engineering faculty at Monash University, Malaysia; the School of Pharmacy at the University of Nottingham, Malaysia; and the Pharmacy faculty at University Kebangsaan Malaysia. He graduated from Middlesex University, UK, in 1982 and attended the Harvard Senior Management Development Program in 2000.
Topic: Accessibility to Affordable Cancer Drugs: Challenges and Opportunities in Malaysia
Theme: Treatment
Session: Determinants of Health
Date: 22 June 2024
Time: 2:20 PM
Mrs Bawani Selvam
Clinical Trials Manager
Clinical Trial Unit
Cancer Research Malaysia
Mrs. Bawani Selvam has a total of seven years of experience in the planning and management of clinical trials across multiple therapeutic areas, including oncology, haematology, autoimmune diseases, and gastroenterology. Her expertise encompasses a wide range of critical functions, such as feasibility assessment, study start-up, site selection, site initiation, site monitoring, and site close-out processes. She is also proficient in data collection, trial documentation, and budget oversight. Currently serving as the Clinical Trials Manager at Cancer Research Malaysia, Mrs. Bawani Selvam oversees all oncology trials, providing pivotal leadership and support to clinical research associates. She plays a key role in expanding the Clinical Trial Unit’s portfolio by collaborating with diverse stakeholders to identify and address unmet needs in cancer research and treatment. This collaborative approach has successfully initiated three investigator-led clinical trials aimed at improving patient outcomes. In 2022, she was one of the top six oral presenters at ASCOMOS, where she shared impactful findings from an Investigator-Initiated trial.
Topic: Low Dose Immunotherapy: The Need for Evidence to Improve Access to Expensive Therapies?
Theme: Treatment
Session: Research
Date: 22 June 2024
Time: 2:20 PM
Ms Ho Chiou Yi
Dietitian
National Cancer Institute, Putrajaya
Ms Ho Chiou Yi is a highly respected clinical dietitian with 15 years of experience in medical nutrition therapy for surgery and oncology patients in government healthcare settings. Ms Ho boasts an impressive academic record. Her dedication to this specialized field is evident in her in-depth understanding of the unique nutritional challenges faced by individuals undergoing cancer treatment or surgery procedures. She is actively involved as part of the nutrition therapy team and her extensive experience allows her to create individualized nutrition care plans that optimize recovery and support overall well-being, especially perioperative medical nutrition therapy in the surgical gynaecologic, colorectal, and upper gastrointestinal cancer cases. This expertise makes her a valuable resource for healthcare professionals and patients alike. After graduating with a Bachelor Science of (Dietetics) at UKM, she continued her research focus with a Master’s in Clinical Nutrition (UPM), achieving a perfect CGPA and the Best Thesis Award. Currently pursuing a PhD, Ms Ho’s dedication to lifelong learning is undeniable. Her dedication to research is underscored by her publications in esteemed journals and numerous conference presentations. Notably, her passion for improving patient care through medical nutrition therapy has earned her prestigious accolades, such as the Dietetic Research Award and the Best Investigator Award which further solidify her reputation as one of the key figures in clinical nutrition research and patient care enhancement.
Topic: Nutrition Approach in Ostomy Management, What’s new?
Theme: Treatment
Session: Allied Health Professional
Date: 22 June 2024
Time: 2:40 PM
Deepti Saraf
General Manager, Pharmaceutical Division, Roche (Malaysia) Sdn Bhd
Vice President of Pharmaceutical Association of Malaysia (PhAMA)
Deepti brings 20 years of experience in the pharmaceutical industry in India and Thailand. She has worked across multiple disease areas including Primary Care, Oncology, Comprehensive Genomic Profiling, I2O, and Nephrology. In India, she established a rural healthcare commercial model and developed an integrated access strategy for Roche. In Thailand, she implemented the Thai Genomics version 4.0, enhancing personalized healthcare outcomes. She has been part of leadership teams in both countries.
As Chief Transformation Officer in Thailand in 2019, Deepti led the agile transformation of the Thai affiliate and contributed to initiatives like Mission Leapfrog, fostering an integrated network with external stakeholders. Her international exposure includes working on health technology solutions to build healthcare infrastructure.
Deepti sponsors the APAC Women’s Cancer Care Coalition, aiming to provide better, faster, and earlier cancer care access for women in APAC. The coalition unites various stakeholders to advocate for women’s cancer care issues. She is committed to fostering a culture of empowered decision-making, innovation, and experimentation for patient benefits.
Passionate about women’s healthcare and leadership in the APAC region, Deepti mentors many women in the healthcare sector and healthcare professionals for the City Cancer Challenge Foundation. She also sponsors women’s cancer initiatives for APAC in Roche. Deepti graduated in Microbiology and Biotechnology from Mumbai and holds an MBA in Marketing and e-Business.
Topic: Panel Discussion: Partnership for Cancer Funding Innovation
Theme: Treatment
Session: Determinants of Health
Date: 22 June 2024
Time: 2:40 PM
Madam Chan Chu San
Breast Cancer Survivors
Madam Chan Chu San is a retired government secondary school teacher, married with two sons. She was diagnosed with stage 2 breast cancer in 2008, which advanced to the liver in 2014. She is a member of the Breast Cancer Welfare Association and founded the Pink Inspirers, the metastatic breast cancer support group of BCWA. She love being active and enjoy bowling, hiking, camping, and traveling.
Topic: Panel Discussion: Partnership for Cancer Funding Innovation
Theme: Treatment
Session:Determinants of Health
Date: 22 June 2024
Time: 2:40 PM
Chiharu Mizoguchi MD
Medical Staff
Department of International Clinical Development
Clinical Research Support Office
National Cancer Center Hospital, Japan
Dr Mizoguchi graduated with his MD from the Oita Medical University in 2009. From 2011 to 2021, she worked as a gynecologist at Oita University Hospital. She joined the National Cancer Center Hospital in 2021 as a medical staff to receive training of medical oncology and learned methodology and management of clinical research. Serving as a coordinating physician in several NCCH studies including MASTER KEY Asia, she has actively engaged in crucial aspects of clinical research. Through ATLAS project she will contribute to development of the partnerships with Asian investigators and to expand clinical trials throughout Asia.
Topic: A Pan-Asia Platform Study for Precision Medicine: MASTER KEY Asia
Theme: Treatment
Session: Research
Date: 22 June 2024
Time: 2:40 PM
Dr Nurul Nadia binti Jamaluddin
Breast and Endocrine Surgeon
Dr Nurul Nadia binti Jamaluddin is a highly accomplished breast and endocrine surgeon with extensive experience in surgical management and specialized training in recurrent laryngeal nerve reconstruction and primary anastomosis. She obtained her Bachelor of Medicine and Bachelor of Surgery (MBBS) from the University of Malaya in 2006. She completed her Master of Surgery (MS) at the National University of Malaysia in 2015. Further honing her expertise, she undertook a fellowship in Breast and Endocrine Surgery at Pusat Perubatan UKM and Hospital Putrajaya and a specialized fellowship in Breast Oncoplastic Surgery at the University Malaya Medical Centre.
Dr Nurul Nadia has held key positions across several prominent hospitals, including Hospital Tuanku Jaafar Seremban, Hospital Umum Sarawak, Hospital Tengku Ampuan Najihah, and Hospital Port Dickson. Her clinical interests focus on breast and endocrine surgeries, specifically recurrent laryngeal nerve monitoring and cervical lymph node dissection for thyroid malignancies.
Dr Nurul Nadia’s commitment to advancing medical knowledge is evident in her active contributions to medical literature. She has published numerous articles in esteemed journals such as the World Journal of Endocrine Surgery, a testament to her dedication and expertise. She has also presented her research at various international conferences. Dr Nurul Nadia is a recognized faculty member and speaker at several high-profile medical workshops and seminars, further emphasizing her commitment to advancing surgical education and practice.
Topic: Endocrine Surgery as Treatment for Cancer
Theme: Treatment
Session: Medical Professional
Date: 22 June 2024
Time: 3:00 PM
Dr Zalina Abu Zaid
Senior Lecturer and Dietitian
Universiti Putra Malaysia
Dr Zalina Abu Zaid is dietetics program coordinator and dietitian in Department of Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia. She graduated her PhD in Flinders University, South Australia. She has a vast experience in dietetics, clinical nutrition, community nutrition (non-communicable disease, obesity and malnutrition), cancer, and surgical. Her publications and research interests addressed nutritional status (malnutrition), risk factors of developing cancer i.e. colorectal cancer, head and neck cancer, breast cancer and nutritional management of cancer and surgical patient. These contributed towards understanding the risk factors esp. modifiable factors (diet and lifestyle factors) in developing cancer, as well as the nutrition intervention to prevent and manage the cancer. She is a member of Malaysian Dietitians’ Association
Topic: Future Directions of Medical Nutrition Therapy in cancer care
Theme: Treatment
Session: Allied Health Professional
Date: 22 June 2024
Time: 3:00 PM
Emeritus Prof Dr Cheong Soon-Keng
Emeritus Professor
Universiti Kebangsaan Malaysia (UKM) and Universiti Tunku Abdul Rahman (UTAR)
Professor Cheong holds the prestigious titles of Emeritus Professor at both Universiti Kebangsaan Malaysia (UKM) and Universiti Tunku Abdul Rahman (UTAR), serves as Deputy Chairman of the UTAR Hospital Board. Recognized for his pioneering haemopoietic stem cell transplant work, he holds esteemed titles such as Professor Emeritus at UKM. A prolific researcher, he has authored over 500 publications, focusing on blood disorders and stem cell applications in regenerative medicine. In addition to academia, he leads as President of the College of Pathologists (CPathAMM) and Vice-President of the National Cancer Council (MAKNA), which received the Merdeka Award in 2021.
Topic: The Emerging Field of Cell-Based Immunotherapy for Cancers
Theme: Treatment
Session: Research
Date: 22 June 2024
Time: 3:00 PM
Dr Norhidayu Salimin
Clinical Oncologist
National Cancer Institute
Ministry of Health Malaysia
Dr Norhidayu Salimin is a Clinical Oncologist currently working in National Cancer Institute, Putrajaya since 2021. She treats multiple solid tumour sites with systemic & radiation therapy, and is heavily involved in multidisciplinary discussions for breast, head & neck, upper gastrointestinal and hepatobiliary cancers. She partakes in multiple clinical trials and is an active member of national & international oncological societies. Her vision is to improve access to specialized cancer treatment in Malaysia and to provide patients with a dignified and optimal cancer care.
Topic: Surviving Through the Storm: Management of Side Effects During Cancer Treatment
Theme: Survivorship
Session: Medical Professionals
Date: 23 June 2024
Time: 9:00 AM
Ms Sudha Kudva
Director
ABRI Mental Health
Ms. Sudha Kudva, a Registered and Licensed Counsellor in Malaysia, brings a wealth of expertise to her practice. With a Master’s in Counselling from the University of Malaya and a background in Biochemistry, she specialises in play therapy, Eye-Movement Desensitization and Reprocessing (EMDR) therapy, and attachment theory. Ms. Sudha Kudva is an author, workshop creator, and facilitator, offering accredited CPD workshops and online sessions grounded in Polyvagal theory.
Ms. Sudha Kudva holds additional qualifications in Emotionally Focused Therapy for Couples and Eye-Movement Desensitization and Reprocessing (EMDR). At ABRI, Ms. Sudha Kudva guides individuals, couples, and families through complex relationship dynamics, addressing issues such as childhood wounds, infidelity, and expatriation stress.
Through her work, she emphasises the profound impact of childhood experiences on adult lives, advocating for healthier interactions to foster secure attachment in children and alleviate behavioral symptoms.
Ms. Sudha Kudva is also the Author of book “Childhood Matters: How We Interact With Kids Makes A Big Difference.”
Topic: Empowering Recovery: The Crucial Role of Mental Health
Support in childhood cancer survivors
Theme: Survivorship
Session: Allied Health Professionals
Date: 23 June 2024
Time: 9:00 AM
Dr Terence Tan
Healthcare/ Life Sciences Lead
Venture Capital and Startups, Asia Pacific and Japan Amazon Web Services
Dr. Terence Tan is a seasoned primary care physician with a great background in healthcare and life science innovation, specializing in Clinical A.I, Clinical UX, Occupational Health, and Nutrition. At Amazon Web Services, he leverage his expertise to support Healthcare & Life Sciences startups, guiding them through technical and regulatory challenges to scale and succeed. His work embodies a unique blend of entrepreneurship, clinical insight, and a keen understanding of regulatory and quality standards, aimed at revolutionizing healthcare access and delivery.
Passionate about making high-quality healthcare accessible to all through technology, Dr. Terence Tan champions the principles of speed and efficiency in healthcare innovation. He believe in the power of quick, effective solutions to improve patient care and outcomes. With a strong commitment to connecting with others in the field, Dr. Terence Tan is a fervent advocate for collaboration and dialogue in the pursuit of advancing healthcare technology and practices.
Topic: Panel Discussion: Digital Health and Cancer Care
Theme: Survivorship
Session: Determinants of Health
Date: 23 June 2024
Time: 9:00 AM
Mr G Saravanan
Chief Information Officer
Thomson Hospital Kota Damansara
A seasoned Chief Information Officer (CIO), currently spearheading Thomson group’s information technology division, managing team on the best processes for healthcare IT excellence. Experienced in IT strategy for the healthcare industry, to ensure that all systems necessary to support its operations and objective, are successful.
Worked throughout South East Asia and Middle East in Hospital environment both as client & consultant. Well versed in Healthcare IT 5G strategy, Hospital IT Operations, Hospital Systems, Telemedicine Device eco-systems, Business Processes, Complying with Legal frameworks, Healthcare Data Management, Standards Adoption, Development & Implementation, Project Management, Enterprise Architecture, Infrastructure, Business Architecture, Solution Architecture to software requirements analysis, design, development and software deployment. Certified in Prince2, SNOMED CT, HL7 RIM, ICD 10.
Topic: Panel Discussion: Digital Health and Cancer Care
Theme: Survivorship
Session: Determinants of Health
Date: 23 June 2024
Time: 9:00 AM
Associate Prof Dr Piyanee Yobas
Alice Lee Centre for Nursing Studies,
National University of Singapore (NUS)
Associate Professor Dr Piyanee Yobas is an academic staff at Alice Lee Centre for Nursing Studies, National University of Singapore. Dr Yobas was born and raised in Thailand, where she developed an early passion for healthcare and education. She pursued her Bachelor of Science (Nursing & Midwifery) at Mahidol University, Thailand where she demonstrated a strong commitment to patient care. She continued her studies, earning a Master of Science, followed by a PhD degree in Nursing from Case Western Reserve University, USA.
Dr Yobas’s research interests have a particular focus on mental health, stress management and psychological interventions on both healthy individuals and patients with chronic conditions, including cancer. Her work has explored psychological aspects of individuals, encompassing strategies to enhance their mindfulness, resilience, and psychological well-being. Currently, she has investigated the impact of digital mindfulness-based intervention (Digital-MindCAN) on health outcomes among cancer survivors. Dr Yobas has been awarded more than 20 research grants. Her research has been published in peer-reviewed journals and presented at international conferences, earning her recognition as one of the World top 2% most cited scientists in year 2022 and 2023. According to Google Scholar, her work has received 6282 citations with the h-index of 41.
Topic: Mindfulness and Survivorship
Theme: Survivorship
Session: Research
Date: 23 June 2024
Time: 9:00 AM
Dr Saiful Adni bin Abd Latif
Palliative Physician
Palliative Medicine and Supportive Care Department
National Cancer Institute, Putrajaya
Dr Saiful Adni Abd Latif is a palliative physician working at the National Cancer Institute, Putrajaya. During his training, he has worked in various places including Selayang Hospital, the National Cancer Institute (Putrajaya), University of Malaya Medical Centre (UMMC), Hospis Malaysia, and Kuala Lumpur Hospital. He has also completed his fellowship under the Medical Training Initiative Programme sponsored by the Royal College of Physicians (UK) at St. Benedict’s Hospice and Centre for Specialist Palliative Care in Sunderland, United Kingdom. Prior to this, he was working full-time as the Head of Unit and Palliative Physician at Malacca General Hospital. Currently, he is working at the National Cancer Institute in Putrajaya and also overseeing the Palliative Care Unit at Malacca General Hospital as a visiting specialist. His areas of interest are psychosocial aspects in coping with life-limiting illness and advocacy for the field of palliative care. He has been involved in organizing events to promote palliative care and communication training for nurses and junior doctors to properly address the psychosocial aspects for patients.
Topic: What’s Next? Long Term Cancer Survivorship and Living with Cancer
Theme: Survivorship
Session: Medical Professionals
Date: 23 June 2024
Time: 9:20 AM
Ms Veni Venusha Sakhti
PhD student
University Malaya
Veni is currently pursuing her PhD in Public Health from University Malaya, with a special interest in the area of cancer epidemiology and financial toxicity in cancer patients. Veni graduated with a Bachelors’ degree in Biohealth Science from University Malaya, and later on pursued a Masters in Medical Sciences (Public Health) from the Medical Faculty of University Malaya. She also holds an MBA obtained from Universitay Putra Malaysia (UPM).
Veni comes with over 14 years of experience in the pharmaceutical industry, where she is heavily involved in managing Phase IV and post marketing trials of medical therapies for patients in various therapeutic areas. Through her PhD research, Veni aims to identify the financially vulnerable population in Malaysia amongst cancer patients and survivors, to allow for rectification measures to be taken from all angles. Through her work, she hopes that she would be able to aid cancer patients in their disease management journey
Topic: Post-COVID Financial Toxicity of Cancer in Malaysia
Theme: Survivorship
Session: Allied Health Professional
Date: 23 June 2024
Time: 9:20 AM
Dr Mark Cheong Wing Loong
Senior Lecturer, School of Pharmacy
Monash University Malaysia
Dr Mark Cheong Wing Loong is a public health and palliative care researcher at the School of Pharmacy, Monash University Malaysia. His work focuses on building better, kinder, and more accessible health systems and healthcare services, as well as exploring how adopting a palliative and supportive care lens can improve healthcare for all. Dr Cheong also studies the lived experiences of people who interact with, use, or work in healthcare systems, as well as the unmet needs of people living with complex life-limiting illnesses. He has collaborated with, and provided consultancy to, organisations including the World Health Organization (WHO), the Drugs for Neglected Diseases initiative (DNDi), the Ministry of Health Malaysia, and the Third World Network on health advocacy projects related to palliative care, access to medicines and healthcare, and health inequalities.
Dr Cheong is currently a Visiting Fellow at the United Nations University – International Institute for Global Health, a Visiting Scholar at the Maybank ASEAN Research Center at the Asia School of Business, and a Fellow of the Royal Society for Public Health (FRSPH, UK). He is also a member of the National Palliative Care Services Development Committee, Ministry of Health Malaysia.
Topic: Evaluating the Quality of Life and Needs of Advanced Cancer Patients in Malaysia
Theme: Survivorship
Session: Research
Date: 23 June 2024
Time: 9:20 AM
Dr Tee Sze Chee
Upper GI and General Surgeon
National Cancer Institute Malaysia
Dr Tee Sze Chee currently serves as an Upper GI and general surgeon under Ministry of Health, Malaysia. She completed her Masters of Surgery programme at National University of Malaysia before she pursued in Upper GI subspecialty training in Japan and Malaysia.
Currently, she is practising at National Cancer Institute, Malaysia, one of the main upper GI referring hospital. She served as council member of Malaysian Upper GI Surgical Society (MUGIS) and Parenteral and Enteral Nutrition Society of Malaysia (PENSMA). Her passion lies in nutrition in cancer, ERAS and prehabilitation pathway.
Topic: Enhanced Recovery After Surgery (ERAS) Protocol for Upper Gastrointestinal Cancer Surgery
Theme: Survivorship
Session: Medical Professional
Date: 23 June 2024
Time: 9:40 AM
Dr Anas Nofal
Managing Partner
Axios International
Dr Anas Nofal, Managing Partner of Axios International since 2011, has significantly expanded the company’s presence in the Middle East, Africa and Asia region through his leadership and expertise. He is a well-rounded healthcare professional with experience in clinical practice, program design, implementation, and compliance and is currently overseeing the global operations of Axios International. Dr Anas is passionate about providing access to quality healthcare services, reducing healthcare inequalities, and addressing patient needs through innovative and sustainable solutions. Dr Anas oversees strategic planning, business development, project implementation, and relationships for all Axios’ healthcare access programs with stakeholders including charity organizations, the pharmaceutical and insurance industries, healthcare providers, regulators, medical associations, and more. He has successfully established unique and sustainable strategies to access patient support programs and fostered public-private partnerships. Dr Anas holds a PhD in Public Health and a Master’s Degree in Business Administration from Vinayaka Missions University (India), and a Bachelor of Science from the University of Jordan. He is fluent in English and Arabic.
Topic: Navigating Survivorship: Ecosystem-Based Approach with the Patient Needs Assessment Tool (PNAT) for Personalized Cancer Care
Theme: Survivorship
Session: Allied Health Professional
Date: 23 June 2024
Time: 9:40 AM
Mr Jonathan Teoh
Founder and CEO
Kenanga AN LIVING Silver Impact Scheme (KALSIS)
Jonathan Teoh leads AN LIVING’s foray into Malaysia as the innovation and administrative partner of the Kenanga AN LIVING Silver Impact Scheme (‘KALSIS’). KALSIS is Asia’s first impact scheme harnessing the power of innovation and capital markets to address the needs of Malaysia’s ageing population. The Scheme enables seniors to unlock wealth from their homes to finance their healthcare needs and enhance their financial resilience in retirement whilst ageing-in-place in the comfort of their homes and familiarity of communities.
AN LIVING is a product of Modern Ageing – an innovation programme jointly administered by NUS Enterprise (the entrepreneurial arm of the National University of Singapore) and ACCESS Health International to catalyse ageing and healthcare related innovations.
Jonathan is a UK-trained architect and multi award-winning marketing professional. His notable career achievements include being part of the vanguard at M+S (a company owned by Malaysia’s Khazanah Nasional and Singapore’s Temasek Holdings) that raised two iconic integrated developments in Singapore worth S$11B, the master-planning of a 4,500-acre development in Iskandar Puteri to power Johor’s growing digital economy and the rebranding of Malaysia-based property developer UEM Sunrise.
Topic: Harnessing the Power of Capital Markets to Help Seniors Battling Cancer Fund Their Treatment and Retirement
Theme: Survivorship
Session: Determinants of Health
Date: 23 June 2024
Time: 9:40 AM
Prof Dr Nur Aishah Mohd Taib
Senior Consultant Breast Surgeon
Faculty of Medicine, University of Malaya
President, Together Against Cancer
Professor Dr. Nur Aishah Taib, a senior consultant breast surgeon and professor in the Department of Surgery at the University of Malaya since 2012, also serves as the Head of the UM Cancer Research Institute since 2019. With a medical degree and various postgraduate qualifications from the University of Malaya, she has conducted extensive research, notably on advanced breast cancer presentation. Prof. Nur Aishah has made significant contributions to medical literature, with 234 peer-reviewed publications and a H-index of 36, focusing on patient care and outcomes.
As a prominent figure in surgical education, she trains Master of Surgery candidates in Malaysia and serves as an examiner for subspecialty exams. Additionally, she has supervised numerous postgraduate students in research and clinical settings. Actively involved in professional organizations, she contributes to national committees and has held leadership roles in surgical societies. She leads local initiatives like the Greater Petaling City Cancer Challenge and research projects like REBUNG and ENPHaSIS, aimed at improving cancer care and survivorship in Malaysia. Furthermore, she demonstrates a commitment to advocacy as the president of Together Against Cancer, a Malaysian NGO.
Topic: The National Strategic Plan for Cancer Control: Our Current Status
Theme: Advocacy and Policy
Session: Medical professionals
Date: 23 June 2024
Time: 11:00 AM
Prof Dr Alvin Ng Lai Oon
Deputy Dean (International)
Department of Psychology
School of Medical and Life Sciences
Sunway University
Psychology at Sunway University. He is a clinical psychologist by training and is now a full-time academic at the university, belonging to the Department of Psychology, under the School of Medical and Life Sciences where he is also Deputy Dean (International). Dr Ng has been an academic for 22 years and a passionate advocate for public mental health literacy. He also holds honorary academic positions at the University of Exeter and the University of East Anglia.
Dr Ng was the Founding President of the Malaysian Society of Clinical Psychology which he helped set up in 2010. He also ran the Master of Clinical Psychology Program at Universiti Kebangsaan Malaysia for 11 years. He was the Secretary of the Asian Cognitive Behavioral Therapies Association where he was instrumental in facilitating professional and public talks on mental health. Dr Ng has given more than 400 talks on psychology and mental health, and has participated as an invited keynote and speaker at numerous conferences locally and internationally.
Topic: Psychosocial Components of Multidisciplinary Cancer Management: Beyond Just Mental Health
Theme: Advocacy and Policy
Session: Allied Health Professionals
Date: 23 June 2024
Time: 11:00 AM
Prof Dr David McCoy
Research Lead
United Nations University International Institute for Global Health (UNU-IIGH)
David McCoy is a renowned public health specialist and professor of global public health, focusing on health systems policy and development, global health governance, international health policy, and the political and economic determinants of health. His recent research endeavors have involved multidisciplinary and multi-sectoral case studies, showcasing his holistic approach to addressing complex health challenges. Dr. McCoy initially trained as a medical doctor at Southampton University and practiced for six years in the UK and South Africa before transitioning to a career in public health.
During his seven-year tenure in South Africa, he played a pivotal role in supporting the post-apartheid transformation of the country’s healthcare system, working with institutions like the University of Cape Town and the Health Systems Trust. Upon returning to the UK, Dr. McCoy has held positions in civil society and the non-government sector, academia, and the public sector, including engagements with organizations like the Peoples Health Movement, Aidspan, Medact, University College London, Queen Mary University London, and the NHS. His diverse experiences across various sectors reflect his commitment to advancing public health on a global scale.
Topic: Political and Economic Determinants of Health in Developing Nations
Theme: Advocacy and Policy
Session: Determinants of Health
Date: 23 June 2024
Time: 11:00 AM
Ms Ho Sweet Lee
Senior Lecturer
Department of Nursing
School of Medical and Life Sciences
Sunway University
Ms. Ho Sweet Lee is a distinguished healthcare professional with over two decades of extensive experience in nursing, healthcare management, education and clinical counselling. Her exceptional expertise and leadership skills have been evident throughout her illustrious career, highlighted by key roles such as oncology nurse educator and nurse manager at a cancer centre of a private hospital since 2000.
In 2011, Ms. Ho transitioned to a lecturing position at a private nursing school, where she fervently shared her knowledge and expertise in Nursing and Oncology Skills. Advancing steadily, she assumed the Head of Nursing School role by 2018.
Driven by a commitment to continuous improvement, Ms. Ho pursued further academic qualifications to enhance her professional capabilities. She obtained a post-basic oncology nursing certification, Bachelor’s degree in Nursing, Specialist Breast Care Nurse certification and a Master’s in Counseling. These achievements have significantly augmented her proficiency in delivering holistic patient care.
Currently, Ms. Ho serves as a Senior Lecturer and Program Lead for post-basic oncology nursing at the School of Medical and Life Sciences in Sunway University. Her unwavering dedication to education and healthcare excellence serves as a beacon of inspiration for future healthcare professionals.
Topic: Empowering Patients Through Comprehensive Care: An Oncology Nurse’s Advocacy Journey
Theme: Advocacy and Policy
Session: Allied Health Professionals
Date: 23 June 2024
Time: 11:20 AM
Dr Mohd Zulhilmi Paiz
Senior Lecturer
Monash University
Dr Zulhilmi is a severe hemophilia B patient who experienced limited medical care in his childhood. Despite the challenges, he has emerged as an advocate for comprehensive hemophilia healthcare access and support groups. His journey began with the receipt of the prestigious international fellowship from the World Federation of Hemophilia (WFH) in 2014, which recognized his exceptional leadership, dedication, and commitment to advancing hemophilia care and advocacy on a global scale. This fellowship propelled him to co-found the ASEAN Hemophilia Network (AHN). Through AHN, Dr Zulhilmi has spearheaded patient empowerment initiatives, strategic management programs, and advocacy for prophylactic treatment in countries such as Singapore, Indonesia, and Myanmar. In addition to his pivotal role in AHN, Dr Zulhilmi actively collaborated with relevant stakeholders to ensure the successful adoption of comprehensive hemophilia treatment in Sabah, Malaysia. His expertise in international advocacy strategy has led to his appointment as an advisor and member of various task forces across several ministries
Topic: Ambassadors Assemble! Cultivating Patient-ambassadors to Advocate for Clinical Trials in Chronic Illnesses
Theme: Advocacy and Policy
Session: Determinants of Health Professionals
Date: 23 June 2024
Time: 11:20 AM
Dr Jue-Sheng Ong
Senior Research Officer
Statistical Genetics
QIMR Berghofer Medical Research Institute
Dr Jue Sheng Ong is a statistical geneticist and Malaysian diasporic scientist at the QIMR Berghofer Medical Research Institute in Brisbane, Australia. His expertise lies in designing and performing genetic analysis workflow on extensive datasets and biobanks. Ong earned his Bachelor of Actuarial Studies and Master of Mathematical Sciences from the Australian National University and completed his PhD in Statistical Genetics at the University of Queensland.
As a disease-agnostic researcher, Ong has collaborated with numerous global consortia, contributing to significant genetic discoveries across a wide range of human conditions (incl. cancers). His commitment to making genomic medicine accessible is bolstered by a prestigious 5-year Investigator Fellowship from the Australian National Health and Medical Research Council (NHMRC), aimed at understanding the genetic basis of age-related diseases in under-represented populations. Ong has spearheaded collaborative programs and conceptual frameworks to build capacity for genetic research targeting diverse populations in Australia and internationally, including the establishment of the QIMR Genetics of Diverse Ancestry program. His recent work addresses key issues in genomics and precision medicine, such as the feasibility of genetic studies in resource-constrained settings, the translation of genomics for patient stratification, promoting research participation among culturally and linguistically diverse (CALD) communities, ensuring equitable data practices, and highlighting the role of diasporic scientists in bridging research communities.
Topic: Increasing Genomic Diversity in Medical Research: The Science, The People and The Culture
Theme: Advocacy and Policy
Session: Research
Date: 23 June 2024
Time:11:20 AM
Associate Professor Dr Murallitharan Munisamy
Managing Director, National Cancer
Society Malaysia (NCSM),
Co-chairperson, Non-Communicable Diseases (NCD) Malaysia
Dr Murallitharan Munisamy is a Public Health Physician from Malaysia. He trained as a Medical Officer in the Russian Federation under a Malaysian government scholarship and completed a Master’s in Community Health Sciences at the National University of Malaysia. He earned a PhD in Public Health from Chulalongkorn University, Thailand, under the ASEAN Economic Community program. In 2015, he received the Chevening Scholarship from the UK Foreign and Commonwealth Office, completing a term as a Fellow in Health Policy, Planning, and Financing at the London School of Hygiene and Tropical Medicine and the London School of Economics and Political Science.
Before his medical career, Dr Murallitharan was an award-winning journalist for the New Straits Times, a leading English newspaper in Malaysia. In medicine, he has served in various roles, including medical officer and clinician at Hospital Kuala Lumpur and the National Blood Bank, clinical epidemiologist for the Clinical Research Centre, Ministry of Health, Malaysia, and Medical Director of MMPKV Healthcare Sdn Bhd. He is deeply involved with healthcare services for marginalized and underprivileged groups, working with organizations like the Tzu Chi Foundation, Sathya Sai Baba Organisation of Malaysia, Divine Life Society of Malaysia, Assunta Hospital, and the Society of St. Vincent de Paul.
Dr Murallitharan’s interests lie in public health, health systems, and health economics. He collaborates with Chulalongkorn University, the University of Tokyo, the London School of Hygiene and Tropical Medicine, and the London School of Economics. He is currently the Medical Director of the National Cancer Society of Malaysia
Topic: Enhancing Skills-Based Training in Screening, Diagnosis and Treatment
Theme: Advocacy and Policy
Session:Medical Professionals
Date: 23 June 2024
Time: 11:40 AM
Prof Dr Chin Kin Fah
Consultant General Surgeon
Professor in Surgery
Founder and Chairman, Academy For Silent Mentor
Professor Dr. Chin Kin Fah is a distinguished laparoscopic surgeon based in Malaysia, known for his expertise in minimally invasive laparo-endoscopic surgery, surgical oncology, gastrointestinal surgery, bariatric and metabolic surgery, and clinical nutrition. He practices at prestigious hospitals, including Gleneagles Hospital, Kuala Lumpur, and others.
A University of Aberdeen alumnus, he completed his specialist training in the UK, followed by significant roles in Australia and the NHS before returning to Malaysia. As an educator, he has served as a dean at Taylor’s University and now holds professorial roles at UTAR and other institutions.
Prof. Dr. Chin is the founder of the Silent Mentor Programme, aiming to advance medical education and research by encouraging body donation. He also established the Academy for Silent Mentor and a Rapid Tissue Donation Programme for cancer research. His contributions are recognised globally, with multiple publications and leadership roles in various medical societies.
Topic: Cancer and the Silent Mentor
Theme: Advocacy and Policy
Session: Allied Health Professional
Date: 23 June 2024
Time: 11:40 AM
Prof Dr Rosmawati Mohamed
Master, Academy of Medicine of Malaysia (AMM)
Consultant Hepatologist,
University Malaya Medical Centre
Professor Dr Rosmawati Mohamed, serving as a Consultant Hepatologist at the University Malaya Medical Centre, holds significant roles in global and regional hepatitis initiatives. She is the Founding Co-chairperson of the WHO Strategic and Technical Advisory Committee for Viral Hepatitis, contributing to global efforts in combating the disease. Locally, she assumes the role of Master at the Academy of Medicine of Malaysia, overseeing various medical specialties across the country. Actively involved in the Malaysian Medical Council, she influences policies regarding medical specialists’ recognition, training, and professional development. Additionally, she champions hepatitis and cancer advocacy as the President of Hepatitis Free Malaysia, reflecting her commitment to public health. Her multifaceted roles underscore her dedication to advancing healthcare both locally and globally.
Topic: Stakeholder Partnerships For A Comprehensive Approach For Liver Cancer/Hepatocellular Carcinoma
Theme: Advocacy and Policy
Session: Determinants of Health
Date: 23 June 2024
Time: 11:40 AM
Assoc Prof Dr Norie Kawahara
Project Associate Professor
Since 2007 and the time of the Asian Cancer Registry and Information Network meeting held in Nanjing, China, Dr Kawahara has served as a member of UICC-Japan and UICC Asia Regional Office (UICC-ARO). As Representative Director of the Asia Cancer Forum she is involved in public-private collaborations on policy recommendation initiatives that seek to raise cancer on the global health agenda.
Since 2021 she is working as Project Associate Professor at Institute for Advanced Studies on Asia, The University of Tokyo, involved in educational program development for Cross-boundary Cancer Studies on Universal Health Coverage in Asia. She received her doctoral degree from Juntendo University for her research and surveys of the quality of life of prostate cancer patients.